相关实验视频
Updated: Jun 25, 2026

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.5K
概括
肠道Bacillus Calmette-Guérin (BCG) 疗法对于非肌肉侵入性膀癌 (NMIBC) 仍然至关重要. 目前正在进行的研究旨在提高BCG的疗效,减少毒性,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 自1976年以来,静脉注射的Bacillus Calmette-Guérin (BCG) 已经成为非肌肉侵入性膀癌 (NMIBC) 的基石疗法.
- 尽管最初持怀疑态度,BCG在治疗现场癌症 (Tis) 和预防中期和高风险NMIBC中复发方面被证明是有效的.
研究的目的:
- 审查过去48年来NMIBCBCBC治疗的BCG疗法的进展.
- 讨论改善患者选择,剂量,安排和管理BCG相关毒性的方法.
- 探索未来的研究方向,包括转基因BCG和组合疗法.
主要方法:
- 临床试验和科学文献对NMIBC的静脉BCG的综述.
- 分析不断变化的治疗模式,患者选择标准和毒性管理策略.
- 讨论正在进行的关于新型BCG配方和组合免疫治疗方法的研究.
主要成果:
- 在优化BCG剂量,安排和为NMIBC治疗选择患者方面取得了重大进展.
- 改善了对BCG无反应的患者的鉴定,这些患者可能会从激进囊切除术中受益.
- 目前正在进行的研究重点是通过基因改造和组合疗法来提高BCG疗效和降低毒性.
结论:
- 肠道BCG仍然是NMIBC不可或缺的治疗方法,在最初报告成功后近50年.
- 继续研究和改进BCG疗法对于改善治疗结果和应对治疗相关挑战至关重要.
- 未来的策略包括个性化方法,新型BCG变种和组合免疫疗法以克服治疗耐药性.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

